Titre : | BMC Infectious Diseases, Vol.14, Suppl.6 - 19 September 2014 - Viral hepatitis and drug use in Europe |
Auteurs : | J. V. LAZARUS, Éditeur scientifique ; K. A. FENTON, Éditeur scientifique |
Type de document : | Bulletin : Périodique |
Paru le : | 19/09/2014 |
Année de publication : | 2014 |
Langues: | Anglais |
Discipline : | MAL (Maladies infectieuses / Infectious diseases) |
Mots-clés : |
Thésaurus géographique EUROPEThésaurus mots-clés HEPATITE ; USAGER ; INJECTION |
Note de contenu : |
CONTENTS:
- Hepatitis - a devastating epidemic in Europe. Lazarus J.V., Fenton K.A., S1. - No strategy to meet the HCV epidemic. Dalgard O., Mauss S., S2. - Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe. Kautz A., Chavdarova L., Walker M., S3. - Ending the mass criminalisation of people who use drugs: a necessary component of the public health response to hepatitis C. Ford C., Bressan J., S4. - A treatment revolution for those who can afford it? Hepatitis C treatment: new medications, profits and patients. Phelan M., Cook C., S5. - A national multidisciplinary healthcare network for treatment of hepatitis C in people who inject drugs in Slovenia. Maticic M., S6. - The successful implementation of Scotland's Hepatitis C Action Plan: what can other European stakeholders learn from the experience? A Scottish voluntary sector perspective. Wylie L., Hutchinson S., Liddell D., Rowan N., S7. - Improving the quality of needle and syringe programmes: an overlooked strategy for preventing hepatitis C among people who inject drugs. Leicht A., S8. - Consensus for the integrated management of hepatitis C in Portugal. Leite R., S9. - A perspective from drug user organisations on 'ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs'. Corbacho A., Rivera M., Trujillo F., Marti M., Carbonell J., Fernandez F., et al., S10. - A policy-maker's perspective on 'ECDC and EMCDDA guidance: prevention and control of infectious diseases among people who inject drugs'. Farran J.C., S11. - Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities. Heimer R., Eritsyan K., Barbour R., Levina O.S., S12. - HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective. Peters L., Mocroft A., Lundgren J., Grint D., Kirk O., Rockstroh J., S13. - Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries. Maticic M., Videcnik Zorman J., Gregorcic S., Schatz E., Lazarus J.V., S14. - Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey. Spina A., Eramova I., Lazarus J.V., S15. - A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region. Lazarus J.V., Sperle I., Maticic M., Wiessing L., S16. - Hepatitis C in European prisons: a call for an evidence-informed response. Arain A., Robaeys G., Stover H., S17. - Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis. Lazarus J.V., Lundgren J., Casabona J., Wiessing L., Mathei C., Vickerman P., et al., S18. |
Domaine : | Drogues illicites / Illicit drugs |
Sous-type de document : | N° spécial de revue / Special issue of a journal |
Lien : | http://www.biomedcentral.com/bmcinfectdis/supplements/14/S6 |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil